THE EFFECT OF CYPROHEPTADINE AND/OR BROMOCRIPTINE ON PLASMA ACTH LEVELS IN PATIENTS CURED OF CUSHING'S DISEASE BY BILATERAL ADRENALECTOMY
暂无分享,去创建一个
[1] H. Koppeschaar,et al. RESPONSE TO NEUROTRANSMITTER MODULATING DRUGS IN PATIENTS WITH CUSHING'S DISEASE , 1986, Clinical endocrinology.
[2] A. Kennedy,et al. Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine. , 1985, Postgraduate medical journal.
[3] L. Kennedy,et al. Cyclical Cushing's disease: two distinct rhythms in a patient with a basophil adenoma. , 1985, The Journal of clinical endocrinology and metabolism.
[4] C. Francalanci,et al. Cushing’s disease: clinical and laboratory response to bromocriptine therapy , 1984, Journal of endocrinological investigation.
[5] T. Fujita,et al. Effects of bromocriptine and cyproheptadine on basal and corticotropin-releasing factor (CRF)-induced ACTH release in a patient with Nelson's syndrome. , 1984, Endocrinologia japonica.
[6] R. Couch,et al. Prolonged remission of Cushing disease after treatment with cyproheptadine. , 1984, The Journal of pediatrics.
[7] H. Koppeschaar,et al. Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease. , 1983, Acta endocrinologica.
[8] M. Boscaro,et al. EFFECT OF BROMOCRIPTINE IN PITUITARY‐DEPENDENT CUSHING'S SYNDROME , 1983, Clinical endocrinology.
[9] D. Krieger,et al. Prolonged remission of a case of Cushing's disease following cessation of cyproheptadine therapy. , 1983, Acta endocrinologica.
[10] W. Kelly,et al. Cushing's disease treated by total adrenalectomy: long-term observations of 43 patients. , 1983, The Quarterly journal of medicine.
[11] F. Perez-Jimenez,et al. Cyproheptadine-Induced Remission of Cushing's Disease Due to Pituitary Basophil Adenoma , 1982, Drug intelligence & clinical pharmacy.
[12] P. D. Bewsher,et al. Successful pregnancy after cyproheptadine treatment for Cushing's disease. , 1982, European journal of obstetrics, gynecology, and reproductive biology.
[13] G. di Renzo,et al. Role of serotonin in the control of secretion of corticotrophin releasing factor. , 1982, The Journal of endocrinology.
[14] I. Jackson,et al. Long term bromocriptine therapy in Cushing’s disease , 1982, Journal of endocrinological investigation.
[15] S. Lamberts,et al. Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: differences in the regulation of hormone secretion. , 1982, The Journal of clinical endocrinology and metabolism.
[16] D. Aron,et al. Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. , 1982, The Journal of clinical endocrinology and metabolism.
[17] M. Richkind. Cushing syndrome in dogs: treatment with bromocriptine and cyproheptadine. , 1981, Veterinary medicine, small animal clinician : VM, SAC.
[18] Russell Rp,et al. Cyproheptadine in the control of Cushing's disease. , 1981 .
[19] A. Kasperlik-Załuska,et al. TWO PREGNANCIES IN A WOMAN WITH CUSHING'S SYNDROME TREATED WITH CYPROHEPTADINE , 1980, British journal of obstetrics and gynaecology.
[20] J. Klijn,et al. The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome. , 1980, The Journal of clinical endocrinology and metabolism.
[21] I. Jialal,et al. Cyproheptadine therapy in Cushing's disease and Nelson's syndrome. , 1980, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[22] D. Krieger,et al. Sustained remission of Nelson's syndrome after stopping cyproheptadine treatment. , 1980, The New England journal of medicine.
[23] S. M. Atherden,et al. Cushing's disease presenting with growth failure: clinical remission during cyproheptadine therapy. , 1979, Archives of disease in childhood.
[24] D. Riad-fahmy,et al. A simple, direct radioimmunoassay for plasma cortisol, featuring a 125I radioligand and a solid-phase separation technique. , 1979, Clinical chemistry.
[25] B. Ambrosi,et al. Lack of Effect of Antiserotoninergic and/or Dopaminergic Treatment in Patients with Pituitary-Dependent Cushing's Syndrome , 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[26] A. Kasperlik-Załuska,et al. Cyproheptadine in the treatment of Nelson's syndrome. , 1979, Endokrynologia Polska.
[27] A. Kennedy,et al. ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease. , 1978, Acta endocrinologica.
[28] D. Krieger. The central nervous system and Cushing's disease. , 1978, The Medical clinics of North America.
[29] D. Krieger,et al. Cyproheptadine treatment of Nelson's syndrome: restoration of plasma ACTH circadian periodicity and reversal of response to TRF. , 1978, The Journal of clinical endocrinology and metabolism.
[30] I. Gregorová,et al. CYPROHEPTADINE IN CUSHING'S SYNDROME , 1977, The Lancet.
[31] J. Birkenhäger,et al. THE ROLE OF DOPAMINERGIC DEPLETION IN THE PATHOGENESIS OF CUSHING'S DISEASE AND THE POSSIBLE CONSEQUENCES FOR MEDICAL THERAPY , 1977, Clinical endocrinology.
[32] J. L. del Arbol,et al. Lack of responsiveness to bromocriptine of Cushing's disease elevated ACTH. , 1977, Archivos de farmacologia y toxicologia.
[33] A. Isaacs,et al. TREATMENT OF CUSHING'S DISEASE WITH CYPROHEPTADINE , 1977, The Lancet.
[34] K. Shaw,et al. CUSHING'S DISEASE: SUCCESSFUL TREATMENT WITH CYPROHEPTADINE , 1977, The Lancet.
[35] J. V. Van Wyk,et al. Treatment of Cushing disease in Childhood with cyproheptadine. , 1977, The Journal of pediatrics.
[36] L. Rees,et al. Cyproheptadine and Cushing's disease. , 1977, British medical journal.
[37] C. Brook,et al. Cushing's disease: failure of treatment with cyproheptadine. , 1977, British medical journal.
[38] R. Donald,et al. Cyproheptadine for Cushing's disease (cont.) , 1977, The New England journal of medicine.
[39] R. Seeler,et al. Paint removers and carboxyhemoglobin. , 1976, The New England journal of medicine.
[40] D. Krieger,et al. Effectiveness of cyproheptadine in decreasing plasma ACTH concentrations in Nelson's syndrome. , 1976, The Journal of clinical endocrinology and metabolism.
[41] L. Rees,et al. CYPROHEPTADINE IN NELSON'S SYNDROME , 1976, The Lancet.
[42] J. Birkenhäger,et al. Effect of bromocriptine in pituitary-dependent Cushing's syndrome. , 1976, The Journal of endocrinology.
[43] D. Krieger,et al. Cyproheptadine-induced remission of Cushing's disease. , 1975, The New England journal of medicine.
[44] P. Lastowiecki,et al. Use of bromocriptine for treatment of Cushing's disease caused by an adenoma originating from the intermediate lobe of the pituitary. , 1987, Endokrynologia Polska.
[45] D. Krieger. Physiopathology of Cushing's disease. , 1983, Endocrine reviews.
[46] D. Gann,et al. Cyproheptadine in the control of Cushing's disease. , 1981, The Johns Hopkins medical journal.
[47] B. Baranowska,et al. Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report. , 1980, Materia medica Polona. Polish journal of medicine and pharmacy.
[48] CYPROHEPTADINE IN CUSHING’S DISEASE AND NELSON’S SYNDROME , 1980 .
[49] More on cyproheptadine in Cushing's disease. , 1977, The New England journal of medicine.
[50] V. Wynn,et al. A fundamental defect of adrenocortical control in Cushing's disease. , 1968, The Journal of endocrinology.